Host Factors Modulate Nirmatrelvir-Ritonavir Efficacy in COVID-19 Patients: A Viral Dynamics Modeling Study
Liao, Y.; Wang, Y.; Wang, Y.; Ai, J.; Law, B. K.; Lim, D.; Zhou, J.; Wang, H.; Wu, Y.; Chia, P. Y.; Chua, H. K.; Chan, C. E. Z.; Schiffer, J. T.; Owens, K.; Esmaeili, S.; Cowling, B. J.; Cove, M. E.; Saito, H.; Wee, L. E.; Young, B. E.; Ng, T. M.; Chan, E. C. Y.; Ajelli, M.; Zhang, W.; Yu, H.; Ejima, K.
Show abstract
Antiviral therapies such as nirmatrelvir-ritonavir are widely used for COVID-19, yet their real-world effectiveness and sources of heterogeneity in treatment response remain incompletely understood. Here, we integrate longitudinal viral load data from a large cohort of SARS-CoV-2 BA.2-infected patients in Shanghai (n=48,243) with a mechanistic within-host viral dynamics model coupled to pharmacokinetic/pharmacodynamic principles to quantify in vivo antiviral efficacy. We estimate that nirmatrelvir-ritonavir reduces viral production by approximately 55% on average. Treatment response exhibits substantial heterogeneity, with higher efficacy observed in vaccinated individuals and reduced efficacy in older adults. Sensitivity analyses demonstrate that the vaccination effect is robust across model specifications, whereas age-related differences depend on assumptions about early viral kinetics, highlighting structural identifiability challenges when analyzing sparse real-world data. These findings provide a mechanistic interpretation of heterogeneous treatment effects and establish a generalizable framework for integrating real-world clinical data with within-host models to inform antiviral optimization and personalized treatment strategies.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Estimating the potential impact and diagnostic requirements for SARS-CoV-2 test-and-treat programs 95%
- Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections 95%
- Modelling the effectiveness of isolation strategies for managing mpox outbreaks with variable infectiousness profiles 94%
Similar papers in this journal
- Adherence and sustainability of interventions informing optimal control against COVID-19 pandemic 93%
- Drug-combination wide association studies of cancer 92%
- COVID-19 in Italy: targeted testing as a proxy of limited health care facilities and a key to reducing hospitalization rate and the death toll 91%
Similar papers in this journal
- Using machine learning to detect coronaviruses potentially infectious to humans 93%
- Multi-strain modeling of influenza vaccine effectiveness in older adults and its dependence on antigenic distance 93%
- Risk compensation after HIV-1 vaccination may accelerate viral adaptation and reduce cost-effectiveness: a modeling study 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.